RPG Life Sciences Limited (RPGL)

Currency in INR
2,331.20
-18.60(-0.79%)
Closed·
RPGL Scorecard
Full Analysis
Has raised its dividend for 6 consecutive years
RPGL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,300.002,354.40
52 wk Range
1,835.002,974.95
Key Statistics
Bid/Ask
2,320.30 / 2,335.00
Prev. Close
2,349.8
Open
2,340
Day's Range
2,300-2,354.4
52 wk Range
1,835-2,974.95
Volume
9.82K
Average Volume (3m)
29.38K
1-Year Change
19.82%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RPGL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

RPG Life Sciences Limited Company Profile

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Employees
1331
Market
India

Compare RPGL to Peers and Sector

Metrics to compare
RPGL
Peers
Sector
Relationship
P/E Ratio
21.3x31.8x−0.5x
PEG Ratio
0.220.230.00
Price/Book
7.3x3.6x2.6x
Price / LTM Sales
5.9x4.1x3.3x
Upside (Analyst Target)
-11.5%43.5%
Fair Value Upside
Unlock6.5%6.3%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 110.52%
Dividend Yield
1.03%
Industry Median 0.72%
Annualised payout
24.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
15.90 / --
Revenue / Forecast
1.74B / --
EPS Revisions
Last 90 days

RPGL Income Statement

People Also Watch

844.90
SUBR
-2.39%
88.61
MAGL
+4.00%
2,601.30
ANGO
-1.00%
2,705.20
MBFL
-1.53%
282.00
ADTB
+1.27%

FAQ

What Stock Exchange Does RPG Life Sciences Limited Trade On?

RPG Life Sciences Limited is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for RPG Life Sciences Limited?

The stock symbol for RPG Life Sciences Limited is "RPGL."

What Is the RPG Life Sciences Limited Market Cap?

As of today, RPG Life Sciences Limited market cap is 38.61B.

What Is RPG Life Sciences Limited's Earnings Per Share (TTM)?

The RPG Life Sciences Limited EPS (TTM) is 110.52.

When Is the Next RPG Life Sciences Limited Earnings Date?

RPG Life Sciences Limited will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is RPGL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has RPG Life Sciences Limited Stock Split?

RPG Life Sciences Limited has split 0 times.

How Many Employees Does RPG Life Sciences Limited Have?

RPG Life Sciences Limited has 1331 employees.

What is the current trading status of RPG Life Sciences Limited (RPGL)?

As of 05 Aug 2025, RPG Life Sciences Limited (RPGL) is trading at a price of 2,331.20, with a previous close of 2,349.80. The stock has fluctuated within a day range of 2,300.00 to 2,354.40, while its 52-week range spans from 1,835.00 to 2,974.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.